This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Chung, C.-S.
Right arrow Articles by Chang, W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Chung, C.-S.
Right arrow Articles by Chang, W.

 Previous Article  |  Next Article 

J Virol, February 1998, p. 1577-1585, Vol. 72, No. 2
0022-538X/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.

A27L Protein Mediates Vaccinia Virus Interaction with Cell Surface Heparan Sulfate

Che-Sheng Chung,1 Jye-Chian Hsiao,1,2 Yuan-Shau Chang,1,2 and Wen Chang1,*

Institute of Molecular Biology, Academia Sinica, Nankang,1 and Institute of Cell and Molecular Biology, Taipei Medical College,2 Taipei, Taiwan, Republic of China

Received 5 September 1997/Accepted 30 October 1997

Vaccinia virus has a wide host range and infects mammalian cells of many different species. This suggests that the cell surface receptors for vaccinia virus are ubiquitously expressed and highly conserved. Alternatively, different receptors are used for vaccinia virus infection of different cell types. Here we report that vaccinia virus binds to heparan sulfate, a glycosaminoglycan (GAG) side chain of cell surface proteoglycans, during virus infection. Soluble heparin specifically inhibits vaccinia virus binding to cells, whereas other GAGs such as condroitin sulfate or dermantan sulfate have no effect. Heparin also blocks infections by cowpox virus, rabbitpox virus, myxoma virus, and Shope fibroma virus, suggesting that cell surface heparan sulfate could be a general mediator of the entry of poxviruses. The biochemical nature of the heparin-blocking effect was investigated. Heparin analogs that have acetyl groups instead of sulfate groups also abolish the inhibitory effect, suggesting that the negative charges on GAGs are important for virus infection. Furthermore, BSC40 cells treated with sodium chlorate to produce undersulfated GAGs are more refractory to vaccinia virus infection. Taken together, the data support the notion that cell surface heparan sulfate is important for vaccinia virus infection. Using heparin-Sepharose beads, we showed that vaccinia virus virions bind to heparin in vitro. In addition, we demonstrated that the recombinant A27L gene product binds to the heparin beads in vitro. This recombinant protein was further shown to bind to cells, and such interaction could be specifically inhibited by soluble heparin. All the data together indicated that A27L protein could be an attachment protein that mediates vaccinia virus binding to cell surface heparan sulfate during viral infection.


* Corresponding author. Mailing address: Institute of Molecular Biology, Academia Sinica, Narkay, Taipei, Taiwan 11529, Republic of China. Phone: 886-2-789-9230. Fax: 886-2-782-6085. E-mail: mbwen{at}ccvax.sinica.edu.tw.




This article has been cited by other articles:

  • Kalia, M., Chandra, V., Rahman, S. A., Sehgal, D., Jameel, S. (2009). Heparan Sulfate Proteoglycans Are Required for Cellular Binding of the Hepatitis E Virus ORF2 Capsid Protein and for Viral Infection. J. Virol. 83: 12714-12724 [Abstract] [Full Text]  
  • Laliberte, J. P., Moss, B. (2009). Appraising the apoptotic mimicry model and the role of phospholipids for poxvirus entry. Proc. Natl. Acad. Sci. USA 106: 17517-17521 [Abstract] [Full Text]  
  • Ching, Y.-C., Chung, C.-S., Huang, C.-Y., Hsia, Y., Tang, Y.-L., Chang, W. (2009). Disulfide Bond Formation at the C Termini of Vaccinia Virus A26 and A27 Proteins Does Not Require Viral Redox Enzymes and Suppresses Glycosaminoglycan-Mediated Cell Fusion. J. Virol. 83: 6464-6476 [Abstract] [Full Text]  
  • Howard, A. R., Senkevich, T. G., Moss, B. (2008). Vaccinia Virus A26 and A27 Proteins Form a Stable Complex Tethered to Mature Virions by Association with the A17 Transmembrane Protein. J. Virol. 82: 12384-12391 [Abstract] [Full Text]  
  • Nichols, R. J., Stanitsa, E., Unger, B., Traktman, P. (2008). The Vaccinia Virus Gene I2L Encodes a Membrane Protein with an Essential Role in Virion Entry. J. Virol. 82: 10247-10261 [Abstract] [Full Text]  
  • Fogg, C. N., Americo, J. L., Earl, P. L., Resch, W., Aldaz-Carroll, L., Eisenberg, R. J., Cohen, G. H., Moss, B. (2008). Disparity between Levels of In Vitro Neutralization of Vaccinia Virus by Antibody to the A27 Protein and Protection of Mice against Intranasal Challenge. J. Virol. 82: 8022-8029 [Abstract] [Full Text]  
  • Huang, C.-Y., Lu, T.-Y., Bair, C.-H., Chang, Y.-S., Jwo, J.-K., Chang, W. (2008). A Novel Cellular Protein, VPEF, Facilitates Vaccinia Virus Penetration into HeLa Cells through Fluid Phase Endocytosis. J. Virol. 82: 7988-7999 [Abstract] [Full Text]  
  • Nelson, G. E., Wagenaar, T. R., Moss, B. (2008). A Conserved Sequence within the H2 Subunit of the Vaccinia Virus Entry/Fusion Complex Is Important for Interaction with the A28 Subunit and Infectivity. J. Virol. 82: 6244-6250 [Abstract] [Full Text]  
  • Berhanu, A., Wilson, R. L., Kirkwood-Watts, D. L., King, D. S., Warren, T. K., Lund, S. A., Brown, L. L., Krupkin, A. K., VanderMay, E., Weimers, W., Honeychurch, K. M., Grosenbach, D. W., Jones, K. F., Hruby, D. E. (2008). Vaccination of BALB/c Mice with Escherichia coli-Expressed Vaccinia Virus Proteins A27L, B5R, and D8L Protects Mice from Lethal Vaccinia Virus Challenge. J. Virol. 82: 3517-3529 [Abstract] [Full Text]  
  • Knappe, M., Bodevin, S., Selinka, H.-C., Spillmann, D., Streeck, R. E., Chen, X. S., Lindahl, U., Sapp, M. (2007). Surface-exposed Amino Acid Residues of HPV16 L1 Protein Mediating Interaction with Cell Surface Heparan Sulfate. J. Biol. Chem. 282: 27913-27922 [Abstract] [Full Text]  
  • Townsley, A. C., Moss, B. (2007). Two Distinct Low-pH Steps Promote Entry of Vaccinia Virus. J. Virol. 81: 8613-8620 [Abstract] [Full Text]  
  • Chiu, W.-L., Lin, C.-L., Yang, M.-H., Tzou, D.-L. M., Chang, W. (2007). Vaccinia Virus 4c (A26L) Protein on Intracellular Mature Virus Binds to the Extracellular Cellular Matrix Laminin. J. Virol. 81: 2149-2157 [Abstract] [Full Text]  
  • Orynbayeva, Z., Kolusheva, S., Groysman, N., Gavrielov, N., Lobel, L., Jelinek, R. (2007). Vaccinia Virus Interactions with the Cell Membrane Studied by New Chromatic Vesicle and Cell Sensor Assays. J. Virol. 81: 1140-1147 [Abstract] [Full Text]  
  • Crim, R. L., Audet, S. A., Feldman, S. A., Mostowski, H. S., Beeler, J. A. (2007). Identification of Linear Heparin-Binding Peptides Derived from Human Respiratory Syncytial Virus Fusion Glycoprotein That Inhibit Infectivity. J. Virol. 81: 261-271 [Abstract] [Full Text]  
  • Ojeda, S., Domi, A., Moss, B. (2006). Vaccinia Virus G9 Protein Is an Essential Component of the Poxvirus Entry-Fusion Complex. J. Virol. 80: 9822-9830 [Abstract] [Full Text]  
  • Townsley, A. C., Weisberg, A. S., Wagenaar, T. R., Moss, B. (2006). Vaccinia Virus Entry into Cells via a Low-pH-Dependent Endosomal Pathway.. J. Virol. 80: 8899-8908 [Abstract] [Full Text]  
  • Chung, C.-S., Chen, C.-H., Ho, M.-Y., Huang, C.-Y., Liao, C.-L., Chang, W. (2006). Vaccinia Virus Proteome: Identification of Proteins in Vaccinia Virus Intracellular Mature Virion Particles. J. Virol. 80: 2127-2140 [Abstract] [Full Text]  
  • Jones, K. S., Petrow-Sadowski, C., Bertolette, D. C., Huang, Y., Ruscetti, F. W. (2005). Heparan Sulfate Proteoglycans Mediate Attachment and Entry of Human T-Cell Leukemia Virus Type 1 Virions into CD4+ T Cells. J. Virol. 79: 12692-12702 [Abstract] [Full Text]  
  • Townsley, A. C., Senkevich, T. G., Moss, B. (2005). The Product of the Vaccinia Virus L5R Gene Is a Fourth Membrane Protein Encoded by All Poxviruses That Is Required for Cell Entry and Cell-Cell Fusion. J. Virol. 79: 10988-10998 [Abstract] [Full Text]  
  • Chahroudi, A., Chavan, R., Koyzr, N., Waller, E. K., Silvestri, G., Feinberg, M. B. (2005). Vaccinia Virus Tropism for Primary Hematolymphoid Cells Is Determined by Restricted Expression of a Unique Virus Receptor. J. Virol. 79: 10397-10407 [Abstract] [Full Text]  
  • Townsley, A. C., Senkevich, T. G., Moss, B. (2005). Vaccinia Virus A21 Virion Membrane Protein Is Required for Cell Entry and Fusion. J. Virol. 79: 9458-9469 [Abstract] [Full Text]  
  • Patterson, N. A., Smith, J. L., Ozbun, M. A. (2005). Human Papillomavirus Type 31b Infection of Human Keratinocytes Does Not Require Heparan Sulfate. J. Virol. 79: 6838-6847 [Abstract] [Full Text]  
  • Carter, G. C., Law, M., Hollinshead, M., Smith, G. L. (2005). Entry of the vaccinia virus intracellular mature virion and its interactions with glycosaminoglycans. J. Gen. Virol. 86: 1279-1290 [Abstract] [Full Text]  
  • Senkevich, T. G., Moss, B. (2005). Vaccinia Virus H2 Protein Is an Essential Component of a Complex Involved in Virus Entry and Cell-Cell Fusion. J. Virol. 79: 4744-4754 [Abstract] [Full Text]  
  • Ward, B. M. (2005). Visualization and Characterization of the Intracellular Movement of Vaccinia Virus Intracellular Mature Virions. J. Virol. 79: 4755-4763 [Abstract] [Full Text]  
  • Chung, C.-S., Huang, C.-Y., Chang, W. (2005). Vaccinia Virus Penetration Requires Cholesterol and Results in Specific Viral Envelope Proteins Associated with Lipid Rafts. J. Virol. 79: 1623-1634 [Abstract] [Full Text]  
  • Fogg, C., Lustig, S., Whitbeck, J. C., Eisenberg, R. J., Cohen, G. H., Moss, B. (2004). Protective Immunity to Vaccinia Virus Induced by Vaccination with Multiple Recombinant Outer Membrane Proteins of Intracellular and Extracellular Virions. J. Virol. 78: 10230-10237 [Abstract] [Full Text]  
  • Escribano-Romero, E., Jimenez-Clavero, M. A., Gomes, P., Garcia-Ranea, J. A., Ley, V. (2004). Heparan sulphate mediates swine vesicular disease virus attachment to the host cell. J. Gen. Virol. 85: 653-663 [Abstract] [Full Text]  
  • Senkevich, T. G., Ward, B. M., Moss, B. (2004). Vaccinia Virus Entry into Cells Is Dependent on a Virion Surface Protein Encoded by the A28L Gene. J. Virol. 78: 2357-2366 [Abstract] [Full Text]  
  • Hung, J.-J., Hsieh, M.-T., Young, M.-J., Kao, C.-L., King, C.-C., Chang, W. (2004). An External Loop Region of Domain III of Dengue Virus Type 2 Envelope Protein Is Involved in Serotype-Specific Binding to Mosquito but Not Mammalian Cells. J. Virol. 78: 378-388 [Abstract] [Full Text]  
  • Kern, A., Schmidt, K., Leder, C., Muller, O. J., Wobus, C. E., Bettinger, K., Von der Lieth, C. W., King, J. A., Kleinschmidt, J. A. (2003). Identification of a Heparin-Binding Motif on Adeno-Associated Virus Type 2 Capsids. J. Virol. 77: 11072-11081 [Abstract] [Full Text]  
  • Smith, G. L., Vanderplasschen, A., Law, M. (2002). The formation and function of extracellular enveloped vaccinia virus. J. Gen. Virol. 83: 2915-2931 [Abstract] [Full Text]  
  • Smit, J. M., Waarts, B.-L., Kimata, K., Klimstra, W. B., Bittman, R., Wilschut, J. (2002). Adaptation of Alphaviruses to Heparan Sulfate: Interaction of Sindbis and Semliki Forest Viruses with Liposomes Containing Lipid-Conjugated Heparin. J. Virol. 76: 10128-10137 [Abstract] [Full Text]  
  • Lin, T.-H., Chia, C.-M., Hsiao, J.-C., Chang, W., Ku, C.-C., Hung, S.-C., Tzou, D.-L. M. (2002). Structural Analysis of the Extracellular Domain of Vaccinia Virus Envelope Protein, A27L, by NMR and CD Spectroscopy. J. Biol. Chem. 277: 20949-20959 [Abstract] [Full Text]  
  • Wang, F.-Z., Akula, S. M., Pramod, N. P., Zeng, L., Chandran, B. (2001). Human Herpesvirus 8 Envelope Glycoprotein K8.1A Interaction with the Target Cells Involves Heparan Sulfate. J. Virol. 75: 7517-7527 [Abstract] [Full Text]  
  • Mandl, C. W., Kroschewski, H., Allison, S. L., Kofler, R., Holzmann, H., Meixner, T., Heinz, F. X. (2001). Adaptation of Tick-Borne Encephalitis Virus to BHK-21 Cells Results in the Formation of Multiple Heparan Sulfate Binding Sites in the Envelope Protein and Attenuation In Vivo. J. Virol. 75: 5627-5637 [Abstract] [Full Text]  
  • Da Silva, D. M., Velders, M. P., Nieland, J. D., Schiller, J. T., Nickoloff, B. J., Kast, W. M. (2001). Physical interaction of human papillomavirus virus-like particles with immune cells. Int Immunol 13: 633-641 [Abstract] [Full Text]  
  • Giroglou, T., Florin, L., Schäfer, F., Streeck, R. E., Sapp, M. (2001). Human Papillomavirus Infection Requires Cell Surface Heparan Sulfate. J. Virol. 75: 1565-1570 [Abstract] [Full Text]  
  • Hallak, L. K., Spillmann, D., Collins, P. L., Peeples, M. E. (2000). Glycosaminoglycan Sulfation Requirements for Respiratory Syncytial Virus Infection. J. Virol. 74: 10508-10513 [Abstract] [Full Text]  
  • Wünschmann, S., Medh, J. D., Klinzmann, D., Schmidt, W. N., Stapleton, J. T. (2000). Characterization of Hepatitis C Virus (HCV) and HCV E2 Interactions with CD81 and the Low-Density Lipoprotein Receptor. J. Virol. 74: 10055-10062 [Abstract] [Full Text]  
  • Locker, J. K., Kuehn, A., Schleich, S., Rutter, G., Hohenberg, H., Wepf, R., Griffiths, G. (2000). Entry of the Two Infectious Forms of Vaccinia Virus at the Plasma Membane Is Signaling-Dependent for the IMV but Not the EEV. Mol. Biol. Cell 11: 2497-2511 [Abstract] [Full Text]  
  • Schneider-Schaulies, J. (2000). Cellular receptors for viruses: links to tropism and pathogenesis. J. Gen. Virol. 81: 1413-1429 [Full Text]  
  • Afonso, C. L., Tulman, E. R., Lu, Z., Zsak, L., Kutish, G. F., Rock, D. L. (2000). The Genome of Fowlpox Virus. J. Virol. 74: 3815-3831 [Abstract] [Full Text]  
  • Lin, C.-L., Chung, C.-S., Heine, H. G., Chang, W. (2000). Vaccinia Virus Envelope H3L Protein Binds to Cell Surface Heparan Sulfate and Is Important for Intracellular Mature Virion Morphogenesis and Virus Infection In Vitro and In Vivo. J. Virol. 74: 3353-3365 [Abstract] [Full Text]  
  • Moulard, M., Lortat-Jacob, H., Mondor, I., Roca, G., Wyatt, R., Sodroski, J., Zhao, L., Olson, W., Kwong, P. D., Sattentau, Q. J. (2000). Selective Interactions of Polyanions with Basic Surfaces on Human Immunodeficiency Virus Type 1 gp120. J. Virol. 74: 1948-1960 [Abstract] [Full Text]  
  • Iqbal, M., Flick-Smith, H., McCauley, J. W. (2000). Interactions of bovine viral diarrhoea virus glycoprotein Erns with cell surface glycosaminoglycans. J. Gen. Virol. 81: 451-459 [Abstract] [Full Text]  
  • Sanderson, C. M., Hollinshead, M., Smith, G. L. (2000). The vaccinia virus A27L protein is needed for the microtubule-dependent transport of intracellular mature virus particles. J. Gen. Virol. 81: 47-58 [Abstract] [Full Text]  
  • Lalani, A. S., Masters, J., Zeng, W., Barrett, J., Pannu, R., Everett, H., Arendt, C. W., McFadden, G. (1999). Use of Chemokine Receptors by Poxviruses. Science 286: 1968-1971 [Abstract] [Full Text]  
  • Vazquez, M.-I., Esteban, M. (1999). Identification of Functional Domains in the 14-Kilodalton Envelope Protein (A27L) of Vaccinia Virus. J. Virol. 73: 9098-9109 [Abstract] [Full Text]  
  • Hsiao, J.-C., Chung, C.-S., Chang, W. (1999). Vaccinia Virus Envelope D8L Protein Binds to Cell Surface Chondroitin Sulfate and Mediates the Adsorption of Intracellular Mature Virions to Cells. J. Virol. 73: 8750-8761 [Abstract] [Full Text]  
  • Nisole, S., Krust, B., Callebaut, C., Guichard, G., Muller, S., Briand, J.-P., Hovanessian, A. G. (1999). The Anti-HIV Pseudopeptide HB-19 Forms a Complex with the Cell-surface-expressed Nucleolin Independent of Heparan Sulfate Proteoglycans. J. Biol. Chem. 274: 27875-27884 [Abstract] [Full Text]  
  • Trkola, A., Gordon, C., Matthews, J., Maxwell, E., Ketas, T., Czaplewski, L., Proudfoot, A. E. I., Moore, J. P. (1999). The CC-Chemokine RANTES Increases the Attachment of Human Immunodeficiency Virus Type 1 to Target Cells via Glycosaminoglycans and Also Activates a Signal Transduction Pathway That Enhances Viral Infectivity. J. Virol. 73: 6370-6379 [Abstract] [Full Text]  
  • Vazquez, M.-I., Rivas, G., Cregut, D., Serrano, L., Esteban, M. (1998). The Vaccinia Virus 14-Kilodalton (A27L) Fusion Protein Forms a Triple Coiled-Coil Structure and Interacts with the 21-Kilodalton (A17L) Virus Membrane Protein through a C-Terminal alpha -Helix. J. Virol. 72: 10126-10137 [Abstract] [Full Text]  
  • Hsiao, J.-C., Chung, C.-S., Chang, W. (1998). Cell Surface Proteoglycans Are Necessary for A27L Protein-Mediated Cell Fusion: Identification of the N-Terminal Region of A27L Protein as the Glycosaminoglycan-Binding Domain. J. Virol. 72: 8374-8379 [Abstract] [Full Text]  
  • Klimstra, W. B., Ryman, K. D., Johnston, R. E. (1998). Adaptation of Sindbis Virus to BHK Cells Selects for Use of Heparan Sulfate as an Attachment Receptor. J. Virol. 72: 7357-7366 [Abstract] [Full Text]  
  • Wiethoff, C. M., Smith, J. G., Koe, G. S., Middaugh, C. R. (2001). The Potential Role of Proteoglycans in Cationic Lipid-mediated Gene Delivery. STUDIES OF THE INTERACTION OF CATIONIC LIPID-DNA COMPLEXES WITH MODEL GLYCOSAMINOGLYCANS. J. Biol. Chem. 276: 32806-32813 [Abstract] [Full Text]